Fundraising Fox
Switchback Systems
San Francisco Bay Area, US · Founded 2019 · 4 known investors
Find your way into Switchback Systems
Sign up to see every warm intro you have to Switchback Systems
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Switchback Systems team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Switchback Systems develops a benchtop DNA synthesis platform that combines onboard oligonucleotide synthesis and gene assembly, aimed at putting synthetic biology tools directly in scientists' hands. It targets researchers across industries such as pharmaceuticals, agriculture, and plastics, positioning itself in the synthetic biology and DNA synthesis market.
Founders & leadership
Board
Investors · 4
How we know: Ahren Innovation Capital's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · GENERAL INCEPTION's portfolio page · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$18.1M disclosed across 2 rounds · 2020–2024
▶$11.3MraisedAug 2024 · 8 investors · BiotechnologyRule 506(b)
- Mary NoeExecutive Officer, Director
- Craig AsherDirector
- Jason MyersExecutive Officer
- Brian ConnExecutive Officer
- Offering amount
- $15M
- Amount sold
- $11.3M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedOct 2023 · 7 investors · BiotechnologyRule 506(b)
- Mary NoeExecutive Officer, Director
- Timothy RichardsonDirector
- Paul ConleyDirector
- A Craig AsherDirector
- Offering amount
- $12.8M
- Amount sold
- $6.7M
- Proceeds to insiders
- $120K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Switchback Systems do?
- Switchback Systems develops a benchtop DNA synthesis platform that combines onboard oligonucleotide synthesis and gene assembly, aimed at putting synthetic biology tools directly in scientists' hands. It targets researchers across industries such as pharmaceuticals, agriculture, and plastics, positioning itself in the synthetic biology and DNA synthesis market.
- Who are Switchback Systems's investors?
- Switchback Systems's investors include Ahren Innovation Capital, GENERAL INCEPTION, Vertical Venture Partners, OMX Ventures.
- How much funding has Switchback Systems raised?
- Switchback Systems has disclosed $18.1M raised across 2 rounds.
- Where is Switchback Systems headquartered?
- Switchback Systems is headquartered in San Francisco Bay Area, US.